Does CARFILZOMIB Cause Therapy partial responder? 495 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 495 reports of Therapy partial responder have been filed in association with CARFILZOMIB (KYPROLIS). This represents 2.3% of all adverse event reports for CARFILZOMIB.
495
Reports of Therapy partial responder with CARFILZOMIB
2.3%
of all CARFILZOMIB reports
204
Deaths
60
Hospitalizations
How Dangerous Is Therapy partial responder From CARFILZOMIB?
Of the 495 reports, 204 (41.2%) resulted in death, 60 (12.1%) required hospitalization, and 51 (10.3%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 495 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which CARFILZOMIB Alternatives Have Lower Therapy partial responder Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL